Eisai - Creedopedia
About us  |  Why use us?  |  Press  |  Contact us

Topic: Eisai



  
 Eisai - Wikipedia, the free encyclopedia
Myōan Eisai, founder of the Rinzai School of Zen, 12th century.
Myōan Eisai (明菴栄西) (April 20, 1141–July 5, 1215) was a Japanese Buddhist priest, credited with bringing the Rinzai school of Zen Buddhism and green tea from China to Japan.
Born in Bitchu province (modern-day Okayama), Eisai started his studies of Buddhism in a Tendai temple.
http://en.wikipedia.org/wiki/Eisai   (294 words)

  
 Article - Myoan Eisai (Senko Kokushi 1141-1215) - presented by ©NewsFinder.Org - All Rights Reserved
Eisai later made the vinaya rules fundamental to Zen life and inaugurated the revival of Zen monasticism in his homeland.
Eisai developed his Zen teaching in Japan carefully, for he wanted to establish a stable and enduring movement before drawing the attention of the imperial court or the monks of Mount Hiei.
Eisai became convinced as a young monk that the Buddhist schools needed reform, and he set his heart on going to China to garner purer teaching.
http://www.newsfinder.org/more.php?id=366_0_1_0_M   (2897 words)

  
 Eisai vitamin for skin health
7/4/2003 - Japanese pharma firm Eisai has added a new vitamin B2 supplement to its established Chocola BB range.
Chocola BB Plus, which also contains B1 and B6 in larger quantities than its other supplements, is targeted at skin health, said to alleviate skin roughness, acne, stomatitis, and also soothe physical fatigue.
The vitamin B2, in the form of activated phosphate riboflavin sodium, is easily absorbed, and comes in a reduced size tablet, says Eisai, Japan's fourth largest drug maker.
http://www.cosmeticsdesign.com/news/news-NG.asp?id=11191   (317 words)

  
 Recruiting drive in New Jersey for Japanese drug maker, Pharmaceutical News, Cover Story, Jobwerx.com
It's an Eisai promotion, and we're taking that over on behalf of Pfizer.
What does Eisai, with 300 sales reps, offer?
Last year, we grew the number of people here at Eisai by 50 percent.
http://www.jobwerx.com/news/Archives/recuriting_drive.html   (1252 words)

  
 Breaking Through
Next Story: Local companies foresee no major impact from new OT rules
This was the first groundbreaking for a "Japan-related company" he has attended since taking up his post almost two years ago.
Colyer, who marked his 20th anniversary in Andover yesterday, said it was the third groundbreaking he has attended with the company.
http://www.eagletribune.com/news/stories/20040824/BU_001.htm   (982 words)

  
 MedMart ...The Cyber Medical Market by WorldMedic
Eisai Launches CHOCOLA BB PURE An Active Type Vitamin B2 Preparation with Vitamins B6, B1, and C
EISAI Launches SACLON CHEWABLE - Upset Stomach Relief Medication -
EISAI Reaches Settlement of the Patent Infringement Relating to Eitest PIVKA II and Picolumi PIVKA-II
http://www.medmart.worldmedic.com/Domestic/Memberphar/eisai.html   (179 words)

  
 Eisai Co., Ltd. - Company Profile - Computer Business Review
Eisai's second largest product segment, consumer healthcare products, encompasses non-prescription pharmaceuticals, such as the vitamin B2 preparation Chocola BB, the indigestion and heartburn remedy Saclon and the Juvelux series of natural vitamin E preparations, medicated topical treatments, cosmetics, toiletries and personal hygiene products.
This has been taken from the company's 2004 annual report.
The following is a statement from Haruo Naito, president and CEO of Eisai.
http://www.cbronline.com/companyprofile.asp?guid=B9A6F5D9-8EAC-4BCA-AB03-6798009A35B0   (1423 words)

  
 BostonWorks - Eisai Research Institute Jobs and Employer Profile
Our hhc mission means that we regard patients and their families as the most important participants in the health care process and we are dedicated to improving their lives.
Eisai's corporate philosophy focuses on meeting the diverse needs of patients and their families and increasing the benefits that health care provides.We express this philosophy with the phrase "human health care", and continue to concentrate efforts on its realization worldwide.
Today, Eisai is Japan's fourth largest pharmaceutical company.
http://bostonworks.boston.com/research/profiles/eisai_research_institute.shtml   (352 words)

  
 Press Lounge - Press Releases - Archive 2001 - 4 January 2001
Roche Diagnostics and IGEN are currently in litigation over claims surrounding the License and Technology Development Agreement between Roche Diagnostics and IGEN entered in 1992 relating to that same ECL technology.
Roche Diagnostics also claims that IGEN has breached this Agreement by granting additional rights to Eisai in Japan which infringe upon the worldwide, exclusive rights granted to Roche Diagnostics by IGEN under the Agreement.
Roche Diagnostics has asserted several claims against IGEN, including a claim that IGEN induced Roche Diagnostics into entering the License and Technology Development Agreement in 1992 by misstating the scope of Eisai’s ECL rights in Japan, and IGEN’s intentions with respect to the expansion of Eisai’s ECL rights in the future.
http://www.roche-diagnostics.com/press_lounge/press_releases/archive/archive01_0104.html   (390 words)

  
 Eisai Inc pharmaceutical company, research and product information
In the United States, our rapid growth and strong performance result from putting patients and their families first when making decisions and from empowering the people who manage our operations.
Headquartered in Teaneck, New Jersey, we're dedicated to a tradition of genuine concern for people and are driven by the desire to meet the diverse health care needs of patients and their families and caregivers.
This comprehensive training manual is available at no cost to non-profit community organizations with volunteer caregiver programs or plans to start one.
http://www.eisai.com   (377 words)

  
 Gut and Gurgle U
Eisai and Janssen undertake no obligation to correct or update any content or information on this site.
Eisai and Janssen recognize that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country.
Images of people or places displayed on this site are either the property of, or used with permission by, Eisai and Janssen.
http://www.gutandgurgleu.com/legal.html   (1162 words)

  
 Healthcare Sales & Marketing Network News: Eisai Inc. Opens New Facility in Research Triangle Park To Accommodate ...
"Eisai lives their human health care mission every day - working to improve the lives of patients and their families," said Mr.
Aciphex® is also indicated for use as part of the first seven-day treatment for H. pylori infection, the single most common cause of peptic ulcers.
Eisai Inc.'s Research Triangle Park facility manufactures Aricept® (donepezil hydrochloride tablets), the most widely prescribed treatment in the world for the symptoms of mild-to-moderate Alzheimer's disease, and Aciphex® (rabeprazole sodium), indicated for the treatment of symptomatic gastroesophageal reflux disease (GERD) including the healing and symptomatic relief of erosive GERD.
http://salesandmarketingnetwork.com/news_release.php?ID=12702   (1391 words)

  
 The Hindu Business Line : Eisai, GSK in pact for marketing anti-ulcer drug
Eisai's presence in India will be important for its global plans, he added.
Financial Daily from THE HINDU group of publications
EISAI Pharmaceuticals India and GlaxoSmithKline Pharmaceuticals (GSK) have signed a co-promotion agreement to market the former's anti-ulcer drug, Paritec, in India.
http://www.thehindubusinessline.com/2005/05/27/stories/2005052701720200.htm   (476 words)

  
 500-Worker Florida Operation Navy Federal's First Outside HQ Area, Site Selection Online Insider
Competitive pressures also seem to be a major impetus in Eisai's U.S. expansion.
Eisai USA Inc., the company's U.S. subsidiary, already owns the vacant 23-acre (nine-hectare) site for the RandD facility, which will be located some 24 miles (38 kilometers) north of downtown Boston.
"Dramatically expanding our sales force reflects Eisai's exceptional growth in the past five years," Sheldon explained.
http://www.conway.com/ssinsider/pwatch/pw030127.htm   (2083 words)

  
 Frontline: HLS Scum of the week - Eisai
Phone them, write to them, fax them or go round their offices demanding answers - it’s time to make Eisai wish that they had never heard of HLS.
Eisai are animal abusers, when you speak to them remember that in one test alone they killed 48 puppies.
In order to prevent them writhing around or fighting back the terrified animals were restrained in slings.
http://www.skeptictank.org/ecowar/gen01248.htm   (357 words)

  
 Local Tech Wire: Technology, Breaking News, IT Jobs, Skinny, The Skinny, Venture, Entrepreneurship, Biotech, Technology ...
Eisai had an initial plan to expand the facility every three to five years, it says.
The first expansion, completed in May 2001, was expected to meet the company’s space requirements for the next two to four years.
Upon completion of this second expansion, the company says its RTP facility will lead to new job opportunities over the next two years.
http://www.localtechwire.com/article.cfm?u=1068   (202 words)

  
 North Jersey Media Group providing local news, sports & classifieds for Northern New Jersey!
Obviously, Eisai has had a lot of growth in recent years.
Eisai Medical Research, a separate U.S. subsidiary, is headquartered in Ridgefield Park and employs about 175 people.
Where do you see growth going in the next few years?
http://www.bergen.com/page.php?qstr=eXJpcnk3ZjczN2Y3dnFlZUVFeXkyOCZmZ2JlbDdmN3ZxZWVFRXl5NjYzNTA0OCZ5cmlyeTdmNzE3Zjd2cWVlRUV5eTI=   (1434 words)

  
 Eisai Pariet Guide
Eisai Ltd., Hammersmith International Centre, 3 Shortlands, London W6 8EE, UK.
PARIET tablets are used to treat people diagnosed as having active duodenal ulcer, active benign gastric/stomach ulcer (peptic ulcers), symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD) commonly referred to as inflammation of the gullet caused by acid and associated with heartburn, or for long-term treatment of GORD (GORD maintenance).
The name and address of the company holding the Product Licence for PARIET is:
http://www.eisai.co.uk/parietguide.htm   (1702 words)

  
 Drug firm size will quadruple
The company is involved with Lazarus House, the Merrimack Valley Hospice, Andover High School's mentoring program and several other community groups.
The company was recognized by the Merrimack Valley Chamber of Commerce last year for its participation in community service, and Colyer said Eisai was one of the "best corporate residents" in town.
Eisai's expansion, which has been in the works for four years, adds to the growing cluster of medical-device makers and other medical firms in the River Road-Interstate 93 industrial area of West Andover.
http://www.eagletribune.com/news/stories/20040819/FP_001.htm   (579 words)

  
 About Eisai
Eisai Inc. upholds the belief in the dignity, integrity, and value of individual employees, and supports the premise that we are a company which will attract and retain the highest quality employees.
Its tradition of genuine concern for people, its dedication to excellence and its contributions to society have become hallmarks of the company.
Eisai's reputation for honesty, fairness, candor, and respect in all of its business dealings is directly attributable to the conduct of its employees.
http://www.medzilla.com/abouteisai.html   (236 words)

  
 API Synonym... RABEPRAZOLE
Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973/S16 8/1/03 8/15/03 Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973/S15 9/30/02 10/2/02 Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973/S14 9/23/02 9/27/02 ACIPHEX (rabeprazole sodium) Delayed-Release Tablets, 20 mg.
Eisai Medical Research NDA 21-456 NDA 20-973/S-013 11/8/02 11/18/02 11/8/02 4/25/03 Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973/S12 5/29/02 6/3/02 Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973/S9 2/12/02 2/21/02 2/21/02 Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973/S8 08/15/01 04/25/03 Aciphex (Rabeprazole Sodium) Delayed-Release Tablets, Eisai NDA 20-973
If you do not see the VIPPS seal, contact the pharmacy and ask if they are taking steps to receive the VIPPS certification.
http://www.betterchem.com/drugs/RABEPRAZOLE   (176 words)

  
 Drug Store News: Eisai sponsors CE Quarterly retail practice lessons - Category News - Continuing Education Quarterly - ...
Pharmacist also recognize the value of effective communication with patients and caregivers, as evidenced by their high level of participation in previous topics in the Contemporary Retail Practice Program.
Pharmacists' ability to assist consumers with health care needs is built on a knowledge of disease states and available therapeutic approaches.
"Eisai's goal is to achieve better patient outcomes by improving the quality of life of patients and their families," said Linda DaSilva, director of trade relations at Eisai.
http://www.findarticles.com/p/articles/mi_m3374/is_4_24/ai_84237959   (331 words)

  
 Online media mentions for Eisai.
Sunderland's income from Eisai was not reflected in documents that NIH turned over to Congress this year.
We do not have copies of any articles described on this site.
On Dec 13, 2004 in PharmaLive.com (press release), CalbaTech Announces Letter of Intent to Acquire KSE Scientific...
http://www.cancer-help.org/corp/Eisai..html   (749 words)

  
 Eisai And Janssen Pharmaceutica Release: Aciphex (Rabeprazole Sodium) Appro...
Privacy note: BioSpace does NOT collect any of this information.
Janssen Pharmaceutica's international operations are headquartered in Beerse, Belgium, with affiliates in 32 countries; Janssen's U.S. headquarters are based in Titusville, NJ.
Eisai Co., Ltd. (including its subsidiaries) had sales of $2.9 billion in fiscal year 2000* with approximately 14 percent of sales spent for research and development.
http://www.acor.org/drugs/pipeline/news/7920715.story   (970 words)

  
 domain-B : Indian business : industry : Eisai becomes first Japanese pharma firm to enter India
Recently Eisai India signed a co-promotion agreement with GlaxoSmithKline Pharmaceuticals, India to market PARIT, Eisai's original research product in India.
The new company will be called Eisai Pharmaceuticals India Pvt.
This site is best viewed with an 800 x 600 monitor resolution
http://www.domain-b.com/industry/pharma/2005/20050917_eisai.html   (210 words)

  
 NetSci: The Biotech YellowPages - Eisai Corporation of North America
Our company's hhc mission symbol is derived from the letters in Florence Nightingale's signature.
Eisai is a human health care company seeking innovative solutions in disease prevention, cure and care for the health and well-being of people worldwide.
NetSci: The Biotech YellowPages - Eisai Corporation of North America
http://www.netsci.org/Resources/Biotech/Yellowpages/E/eisaicorp.html   (48 words)

  
 Eisai Co Ltd shares from FramedShare.co.uk
This is because the share certificate is registered in your name or the name of a friend if you want to make this a gift.
The contents of this page have been approved by SP Angel and Co Limited which are authorised and regulated by the FSA and is a member of the London Stock Exchange and APCIMS.
• All correspondence will come directly from Eisai Co Ltd once the share certificate is delivered.
http://www.framedshare.co.uk/Product.asp?shareid=9319   (340 words)

  
 Japan Corporate News Network - Eisai's Statement to the AD2000 Clinical Trial Led by the Collaborative Group of the ...
Eisai and Pfizer are confident of the effectiveness of ARICEPT as the No.1 prescribed treatment of Alzheimer's disease supported by the rich evidence reported in 14 double-blind studies and long-term clinical studies.
Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system.
Eisai and Pfizer Limited have reviewed the results of the study, and set the results of this new information in context with all other published evidence.
http://www.japancorp.net/Article.Asp?Art_ID=7678   (521 words)

  
 Interview with Soichi Matsuno, Eisai Inc.: TWST
TWST: Just start by giving us a brief overview of Eisai, the company's history, products, services, customers, those kinds of things, please.
Matsuno: Eisai was founded about 60 years ago in Japan and was conceived as a research-oriented healthcare company from the start.
Eisai CEO seeks to expand Alzheimer's treatment to other illnesses
http://www.twst.com/notes/articles/hap608.html   (646 words)

  
 Newhouse A1
Eisai is one of 18 Japanese pharmaceutical subsidiaries operating in New Jersey, the largest such concentration in the United States.
There, a handful of subsidiaries operated by Japanese drug makers form an enclave, lined up along a state highway in the Chicago suburb of Deerfield.
William Sheldon, president of Eisai Inc., says the pharmaceutical company's parent wants local people, not Japanese, running U.S. operations.
http://www.newhousenews.com/archive/todd030303.html   (779 words)

  
 Fee agreement reached by Eisai, Cardinal Health
Cardinal, AmerisourceBergen, and McKesson are in the midst of an effort to shift from their traditional business model to a fee-for-service arrangement.
The article points out that Pfizer, in a recent earnings report, stated that it would not negotiate with wholesalers about establishing a fee-for-service agreement and that the company believes “that wholesalers purchase and re-sell products for their own account and not as a service to Pfizer as a manufacturer."
Eisai, in a highly publicized move, had previously announced discontinuation of Cardinal Health as a distributor for its products—including donepezil hydrochloride tablets (Aricept), rabeprazole sodium (Aciphex) and zonisamide (Zonegran)—and directed professionals to other suppliers.
http://www.pharmacist.com/articles/h_ts_0721.cfm   (198 words)

  
 Eisai pharmaceutical careers and job opportunities locator and search
If you do not see a position of interest today, please check back again in the near future.
Eisai posts new job opportunities on a daily basis.
When you have finished selecting your search criteria, click on the search button.
http://www.eisai.com/job.asp?ID=145   (106 words)

  
 pteihome
We combine our talents to understand and meet the needs of patients and their families to enhance the quality of life.
Send mail to webmaster@eisai.co.id with questions or comments about this web site.
Eisai is a Human Health Care Corporation, striving for innovative solutions in prevention, cure and care for the health and well being of people worldwide.
http://www.eisai.co.id   (121 words)

  
 Eisai Automates the Creation and Delivery of Sales and Marketing Reports with AOS
For more information on related topics visit the following related portals...
Due to the fact that Eisai has many system measures (80), it causes a long choice list in the selector tool.
Average users do not have this skill set.
http://www.dmreview.com/article_sub.cfm?articleID=2373   (752 words)

  
 Phytomedics Inc. and Eisai Research Institute of Boston, Inc. Enter Cancer Therapeutic Discovery Collaboration :: ...
This synergy presents an opportunity to develop a new generation of novel therapeutics as life-saving drugs for cancer and other diseases."
Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system.
Eisai Research Institute is a wholly-owned subsidiary of Eisai Co., Ltd., a research-based human health care company that discovers, develops and markets products in more than 30 countries.
http://www.npicenter.com/anm/anmviewer.asp?a=2434&z=3   (483 words)

  
 DMHMR, EISAI, PFIZER Cooperate in Alzheimer Study
Funded by a $15,000 Pfizer and Eisai education grant, William Petrie, MD., clinical director of the Memory Disorder Clinic and clinical professor of psychiatry at the Vanderbilt University School of Medicine, will conduct a 30-week study involving patients in the mild to moderate range of Alzheimer’s.
Nashville, TN Over 4,000,000 Americans now have Alzheimer’s Disease, and that number is expected to increase as the population ages, according to Judy Regan, MD., Mental Health Medical Director for the Department of Mental Health & Mental Retardation (DMHMR).
Participating patients will be from Petrie’s private practice.
http://www.state.tn.us/mental/news/pr-alzheimer.html   (325 words)

  
 News Cardinal Health
Cardinal Health undertakes no obligation to update or revise any forward-looking statement.
"Reaching a mutually beneficial business agreement was in the best interest of those who benefit from Eisai's treatments.
With this agreement, both needs have been met with a customized distribution solution that reflects the unique requirements of Eisai's products and the value Cardinal Health provides."
http://www.cardinal.com/content/news/1202005_84643.asp   (450 words)

  
 About Bracco
The joint-venture with Eisai Co., one of the top Japanese pharmaceutical groups, is directed towards the guided development of products originating from Bracco research up to their final approval by the relevant Japanese authorities.
The subsequent promotion and sales are handled by Eisai which is active on the Japanese market through a concentrated network of sales representatives.
About 30 employees presently work for the Bracco-Eisai structure.
http://www.bracco.com/Bracco/Internet/AboutUs/BrEisai.htm   (305 words)

  
 PharmaVitae 2004: Eisai Global & US Analysis - Computer Business Review
This analysis examines the market position and future outlook for Eisai.
Understand the key factors contributing to Eisai's forecast sales decline, at a negative CAGR of 3.2%, between 2003 and 2010
Learn why co-development agreements are expected to be the key to Eisai's future international expansion
http://www.cbronline.com/research.asp?guid=CSHC1182   (158 words)

  
 Medarex Receives Milestone Payment from Eisai Co., Ltd.
"We are pleased by the continuing progress of our partnership with Eisai," said Michael A. Appelbaum, President and COO of the GenPharm subsidiary of Medarex.
Medarex has a number of on-going corporate partnerships based on its fully human monoclonal antibody technology.
MDX-CD4, a human monoclonal antibody designed for the treatment of rheumatoid arthritis and other autoimmune diseases, was developed using Medarex's proprietary HuMAb-Mouse(TM) technology.
http://www.medarex.com/cgi-local/item.pl/19980903-555387   (350 words)

  
 Newly Approved Drug Therapies (761): Aciphex (rabeprazole sodium), Eisai
Aciphex is referred to as Pariet outside of the United States.
Aciphex was discovered and developed by Eisai, and it is co-marketed in the United States by Eisai and Janssen Pharmaceutica.
Newly Approved Drug Therapies (761): Aciphex (rabeprazole sodium), Eisai
http://www.centerwatch.com/patient/drugs/dru761.html   (591 words)

  
 NRI Commissioned to Develop a Data Management System for Eisai's Non-Clinical Activities...utilizing Waters NuGenesis ...
Under such circumstances, Eisai's RandD sector considers it essential to promote the digitization in tripartite research and development—in Japan, the United States and Europe.
And since October 2003, NRI has been verifying the effectiveness of the Waters NuGenesis SDMS as an electronic management tool for the analysis of Eisai's research data.
Since last summer, NRI has been a fully-fledged participant in the pharmaceutical research and development data management field.
http://www.nugenesis.com/pages/news/press_releases/en/2004/pr2004_006_nri.htm   (685 words)

  
 Eisai ends relationship with Cardinal Health
These medications are available in ample supply from other distributors, including AmerisourceBergen and McKesson.
Returns for Eisai products will continue to be processed by Universal Solutions, Inc.
A full list of distributors is available on the Eisai Web site.
http://www.pharmacist.com/articles/h_ts_0712.cfm   (159 words)

  
 Eisai Co., Ltd. - Annual Income Statement - Hoover's
Get more info on Eisai with a DandB Report.
Eisai Co., Ltd. - Annual Income Statement - Hoover's
http://www.hoovers.com/eisai/--ID__56282,period__A--/freeuk-co-fin-income.xhtml   (53 words)

  
 Tradeline, Inc. Eisai Expands in Andover (December 2003)
Tradeline, Inc. Eisai Expands in Andover (December 2003)
If you have an account with TradelineInc.com, please log in now:
http://www.tradelineinc.com/go.cfm?id=A5554920-2B3B-B525-84DC418C07B9CFFE   (28 words)

  
 Hellenic Forums Omogenia - YASOU - Hellenism: SVATSO eisai katharma
JOBS IN Find a USA / CANADA Job
Hellenic Forums Omogenia - YASOU - Hellenism: SVATSO eisai katharma
http://www.omogenia.com/forums/showthreaded.php/Number/9514   (136 words)

  
 Sony Ericsson K500i Eisai to tairi mou Ringtones
Sony Ericsson K500i Eisai to tairi mou Ringtones
Wap ID enter 1449995 at wap.lasyk.net from your wap browser
http://www.myk500.lasyk.net/preview/9995/773616896/K500-Ringtones-Greek-Eisai-to-tairi-mou.html   (46 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Creedopedia.com Usage implies agreement with terms.